COVID-19 could affect the availability and cost of antiretroviral medicines but the risks can be mitigated – Study
Winnie Byanyima, Executive Director of UNAIDS during a conference in Geneva (PHOTO/Courtesy). GENEVA — A new analysis by UNAIDS has ...